Tapentadol (CG5503)

Clinical trial NCT00421928 · COMPLETED

Trial details

NCT number: NCT00421928
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Knee Pain

Start date: 2007-01-01
Primary completion: 2008-07-01
Enrollment: 1030

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.